Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Provention BioEvolusAkebia TherapeuticsRigel PharmaceuticalsOrganiGram
SymbolNASDAQ:PRVBNASDAQ:EOLSNASDAQ:AKBANASDAQ:RIGLNASDAQ:OGI
Price Information
Current Price$11.14$12.20$5.94$2.16$2.69
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$19.88$27.40$13.80$7.50$10.96
% Upside from Price Target78.41% upside124.59% upside132.32% upside247.22% upside307.43% upside
Trade Information
Market Cap$527.36 million$417.81 million$702.95 million$363.71 million$404.50 million
Beta5.884.441.761.37N/A
Average Volume543,872541,1462,191,6391,176,0373,881,054
Sales & Book Value
Annual RevenueN/AN/A$207.74 million$44.51 million$61.27 million
Price / SalesN/AN/A3.408.136.86
CashflowN/AN/AN/AN/A$0.11 per share
Price / CashN/AN/AN/AN/A25.49
Book Value$1.76 per share$3.09 per share$5.44 per share$0.66 per share$1.58 per share
Price / BookN/AN/A1.093.271.70
Profitability
Net Income$-26,480,000.00$-46,870,000.00$-143,590,000.00$-70,480,000.00$-7,200,000.00
EPS($1.19)($1.57)($2.44)($0.44)$0.06
Trailing P/E RatioN/AN/AN/AN/A44.83
Forward P/E RatioN/AN/AN/AN/A13.45
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-75.39%-56.84%-11.16%
Return on Equity (ROE)-64.75%-188.09%-32.74%-52.74%-7.21%
Return on Assets (ROA)-60.94%-52.68%-20.44%-29.78%-5.28%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A4.53%0.06%0.45%0.14%
Current Ratio19.43%3.66%1.34%4.06%4.47%
Quick Ratio19.43%3.28%0.82%4.03%1.88%
Ownership Information
Institutional Ownership Percentage12.94%16.94%70.41%88.03%11.75%
Insider Ownership Percentage19.60%3.90%2.66%4.96%N/A
Miscellaneous
Employees1370324158615
Shares Outstanding47.64 million33.42 million118.94 million167.61 million156.18 million
Next Earnings Date3/17/2020 (Estimated)3/16/2020 (Estimated)3/24/2020 (Estimated)2/27/2020 (Estimated)1/27/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel